Dexcom (DXCM) Free Cash Flow (2010 - 2026)

Dexcom (DXCM) has 17 years of Free Cash Flow data on file, last reported at $449.0 million in Q1 2026.

• Free Cash Flow for Q1 2026 came in at $449.0 million, up 363.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 billion (up 148.5% YoY), and the FY2025 annual result was $1.1 billion, up 70.79% from the prior year.
• Free Cash Flow grew to $449.0 million in Q1 2026 per DXCM's latest filing, from $192.1 million in the prior quarter.
• Over five years, Free Cash Flow peaked at $579.4 million in Q3 2025 and troughed at -$30.6 million in Q1 2022.
• A 5-year average of $174.9 million and a median of $152.3 million in 2024 frame the typical range for Free Cash Flow.
• The sharpest annual moves came in 2024 and 2025: Free Cash Flow tumbled 59.64% in 2024, then jumped 556.17% in 2025.
• A 5-year view of Free Cash Flow shows it stood at $69.0 million in 2022, then increased by 17.54% to $81.1 million in 2023, then soared by 118.0% to $176.8 million in 2024, then advanced by 8.65% to $192.1 million in 2025, then jumped by 133.73% to $449.0 million in 2026.
• Business Quant data shows DXCM's Free Cash Flow at $449.0 million in Q1 2026, $192.1 million in Q4 2025, and $579.4 million in Q3 2025.